OverT Bio Receives $120K G-Rex® Grant To Propel Tumor Cell Therapy
22 Nov 2024 //
BUSINESSWIRE
OverT Bio raises $16 million for innovative immune cell therapies.
06 May 2024 //
BUSINESSWIRE
22 Nov 2024 //
BUSINESSWIRE
06 May 2024 //
BUSINESSWIRE